Under construction – not a live service
Sign in
Taking people in United StatesNo phase

Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer

Key facts

Where
Chapel Hill, United StatesSee the site

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 120 years old?

Source: NCT01137643, who can take part

Where in United States

  • Lineberger Comprehensive Cancer Center at University of North Carolina, Chapel HillChapel Hill, United StatesTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
UNC Lineberger Comprehensive Cancer Center
Trial code
NCT01137643
Record updated
28 October 2026
Original description
RATIONALE: Collecting and storing samples of tissue, blood, and body fluid from patients with cancer to study in the laboratory may help the study of cancer in the future.Read full original descriptionShow less

Tissue Procurement For Hematolymphoid Conditions

RATIONALE: Collecting and storing samples of tissue, blood, and body fluid from patients with cancer to study in the laboratory may help the study of cancer in the future.

PURPOSE: This research study is collecting and storing blood and tissue samples from patients being evaluated for hematologic cancer.

DISEASE CHARACTERISTICS:; Diagnosis of abnormal hematopoietic/lymphoid cancer, including any of the following:; Acute myeloid leukemia; Acute lymphoblastic leukemia; Chronic myelogenous leukemia; Chronic lymphoid leukemia; Non-Hodgkin lymphoma; Hodgkin lymphoma; Myelodysplastic syndromes; Myeloproliferative disorders; Multiple myeloma; Waldenstrom macroglobulinemia; Aplastic anemia; Any other diseases that generate abnormalities in either number, function, or both of any cell type of hematolymphoid lineage; Patients who are being evaluated at the hematology/oncology clinics of the University of North Carolina Hospitals, at the stem cell transplant clinic, or in the hospital; PATIENT CHARACTERISTICS:; Not specified; PRIOR CONCURRENT THERAPY:; Not specified.

ClinicalTrials.gov NCT01137643